MEDIAN Assists in Managing Response to Lung, Liver Therapy

May 26, 2009 - MEDIAN Technologies will feature at SIIM 2009 its MEDIAN LMS-Lung and LMS-Liver solutions, designed to assist clinicians in raising the standards of cancer patient care through the communication of automatic reports containing quantitative and reproducible information about lesion growth for an accurate assessment of response to therapy.
Reports can automatically be done according to the RECIST criteria commonly used for clinical trials. Also included in LMS-Lung is a computer-aided detection function for a more reliable diagnosis of lung nodules.
LMS applications can be integrated with existing RIS/PACS workstations in single or multi-site environments in order to bring advanced clinical functionalities right to the radiologists’ desktop, facilitate the communication between all physicians during tumor boards and standardize reporting across cancer care networks for all patients.